The Cancer Research Committee of the American Society of Clinical Oncology (ASCO) recently released a draft of a white paper entitled “Defining clinically meaningful outcomes: ASCO recommendations to raise the bar for clinical trials”. Lee M. Ellis, M.D., immediate past Chair of the Committee and lead author of the draft guidelines, talked to Man Tsuey Tse about the aims and their potential impact on the development of anticancer therapeutics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Lee M. Ellis. Nat Rev Drug Discov 12, 572–573 (2013). https://doi.org/10.1038/nrd4085
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4085
